Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Virion Therapeutics
AddedFeb 15, 2024
UpdatedJun 18, 2026
Virion Therapeutics

Virion Therapeutics

Series B

Virion Therapeutics: A global biotech firm innovating vaccines for cancers and chronic viral infections.

HQ
Newark, DE, US
Founded
2018
Overview
Compare
Fundraising
Employees
Website

Founded as a clinical-stage biopharmaceutical company, Virion Therapeutics focuses on developing innovative T cell-based immunotherapies to treat cancer and chronic infectious diseases. The company's core mission is to enhance and broaden CD8+ T cell responses using genetically encoded checkpoint modifiers (CPMs), aiming to provide more effective treatments for patients globally. Virion Therapeutics leverages cutting-edge biotechnology to create vaccines that address significant unmet medical needs in oncology and infectious disease markets.

Notable figures affiliated with Virion Therapeutics include leading scientists and industry experts in immunotherapy and vaccine development. The company has attracted investment from prominent venture capital firms specializing in biotech innovations. Key achievements include successful preclinical trials demonstrating the efficacy of their CPMs in enhancing immune responses. Virion Therapeutics' impact lies in its potential to revolutionize treatment paradigms for cancer and chronic infections, offering hope for improved patient outcomes worldwide.

Virion Therapeutics - Similar Companies

Vir Biotechnology logo

Vir Biotechnology

vir.bio

Viriom logo

Viriom

viriom.com

IconOVir Bio logo

IconOVir Bio

iconovir.com

Therabiol logo

Therabiol

Virsti Therapeutics logo

Virsti Therapeutics

Precision Virologics logo

Precision Virologics

Viracta Therapeutics logo

Viracta Therapeutics

viracta.com

A2 Biotherapeutics logo

A2 Biotherapeutics

a2bio.com

Via Nova Therapeutics logo

Via Nova Therapeutics

vianovatx.com

Vita Therapeutics logo

Vita Therapeutics

ViTToria Biotherapeutics logo

ViTToria Biotherapeutics

vittoriabio.com

Triumvira Immunologics logo

Triumvira Immunologics

triumvira.com

LTZ Therapeutics logo

LTZ Therapeutics

Vyriad logo

Vyriad

vyriad.com

VintaBio logo

VintaBio

vintabio.com

Virion Therapeutics - Quick Facts

Who are Virion Therapeutics' competitors?

Companies similar to Virion Therapeutics include Vir Biotechnology, Viriom, IconOVir Bio and Therabiol.

When was Virion Therapeutics founded?

Virion Therapeutics was founded in 2018.

Where is Virion Therapeutics' headquarters located?

Virion Therapeutics' headquarters is located in Newark, DE, US.

How much has Virion Therapeutics raised to-date?

As of Jan 1, 2021, Virion Therapeutics has raised a total of $14.1M (USD).

How many employees does Virion Therapeutics have?

Virion Therapeutics has 8 employees as of Feb 5, 2024.

Virion Therapeutics - Classification

Ownership
  • Private
  • Venture Capital
Technology
  • Biotech
Geographic Exposure
  • Global
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
Main Product
  • Immunotherapy
  • Vaccines
Tags
  • Biotech
  • Healthcare
  • Healthtech
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8730Research, Development, And Testing Services
  • 8731Commercial Physical and Biological Research
Show 13 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 620000Health Care and Social Assistance
  • 325000Chemical Manufacturing
  • 623000Nursing and Residential Care Facilities
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 2800Chemicals And Allied Products
  • 8000Health Services
  • 2830Drugs
  • 8040Offices And Clinics Of Other Health Practitioners
  • 2834Pharmaceutical Preparations
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified